Swiss HLG and BaselArea are excited to invite you to the Swiss HLG's 4th start-up workshop collaboration. "Valuation of Early Stage Biotech Companies – Net Present Value versus VC approach." The risk-adjusted, net present value (rNPV) method is the standard valuation method used within pharma and biotech companies when valuing assets beyond discovery stage. This approach depicts the drug/pipeline […]